Quick Answer
Aspire Biopharma Holdings, Inc. reported Shares Outstanding of 3.53 million shares for fiscal year 2025.
Aspire Biopharma Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.53M | +412.1% |
| 2024 | 690,044 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 49.53M | — | +0.0% |
| June 30, 2025 | 49.53M | — | +1590.9% |
| April 30, 2025 | 2.93M | — | -94.0% |
| March 31, 2025 | 48.90M | — | +77.2% |
| December 31, 2024 | 27.60M | — | — |
- Aspire Biopharma Holdings, Inc. showed an increase of +412.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Aspire Biopharma Holdings, Inc.’s shares outstanding has grown by 412.1% (from 690.0 thousand shares to 3.53 million shares).
- The most recent figure is from Aspire Biopharma Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: